Abstract
Objectives
To estimate the safety and effectiveness of emergent transjugular intrahepatic portosystemic shunt (TIPS) creation for acute variceal bleeding (AVB) in cirrhotic patients with hepatocellular carcinoma (HCC).
Materials and methods
Data of thirty-three patients with AVB and HCC undergoing emergent TIPS creation from January 2016 to January 2022 were enrolled and were retrospectively analyzed. The primary outcomes were the safety of emergent TIPS creation, the bleeding control rate, and the rebleeding rate. The secondary outcomes included overall survival (OS), liver function, overt hepatic encephalopathy (HE), and shunt dysfunction.
Results
Emergent TIPS creation was technically successful in 33 patients (100%) and one (3.0%) patient suffered a major procedure-related adverse event. The control rate of bleeding (within 5 days) was 100%. During a median follow-up period of 26.3 months, rebleeding occurred in 6 (18.2%) patients. The median OS was 20.0 months. The 6-week and 1-year survival rates were 87% and 65%, respectively. Laboratory tests showed no significant impairment of liver function following TIPS creation. The incidences of overt HE and shunt dysfunction were 24.2% and 6.1%, respectively.
Conclusion
Emergent TIPS creation is feasible and effective for treatment of AVB in cirrhotic patients with HCC.
Similar content being viewed by others
References
J.Y.W. Lau, Y. Yu, R.S.Y. Tang, H.C.H. Chan, H.C. Yip, S.M. Chan, S.W.Y. Luk, S.H. Wong, L.H.S. Lau, R.N. Lui, T.T. Chan, J.W.Y. Mak, F.K.L. Chan, J.J.Y. Sung, Timing of Endoscopy for Acute Upper Gastrointestinal Bleeding, N Engl J Med 382(14) (2020) 1299-1308.
M. Ibrahim, A. El-Mikkawy, M. Abdel Hamid, H. Abdalla, A. Lemmers, I. Mostafa, J. Deviere, Early application of haemostatic powder added to standard management for oesophagogastric variceal bleeding: a randomised trial, Gut 68(5) (2019) 844-853.
F. Bray, J. Ferlay, I. Soerjomataram, R.L. Siegel, L.A. Torre, A. Jemal, Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J Clin 68(6) (2018) 394-424.
E.G. Giannini, D. Risso, R. Testa, F. Trevisani, M.A. Di Nolfo, P. Del Poggio, L. Benvegnu, G. Ludovico Rapaccini, F. Farinati, M. Zoli, F. Borzio, E. Caturelli, G. Italian Liver Cancer, Prevalence and prognostic significance of the presence of esophageal varices in patients with hepatocellular carcinoma, Clin Gastroenterol Hepatol 4(11) (2006) 1378-84.
R. de Franchis, V.I.F. Baveno, Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension, J Hepatol 63(3) (2015) 743-52.
G. Garcia-Tsao, J.G. Abraldes, A. Berzigotti, J. Bosch, Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases, Hepatology 65(1) (2017) 310-335.
C. Ripoll, J. Genesca, I.K. Araujo, I. Graupera, S. Augustin, M. Tejedor, I. Cirera, C. Aracil, M. Sala, M. Hernandez-Guerra, E. Llop, A. Escorsell, M.V. Catalina, N. Canete, A. Albillos, C. Villanueva, J.G. Abraldes, R. Banares, J. Bosch, Rebleeding prophylaxis improves outcomes in patients with hepatocellular carcinoma. A multicenter case-control study, Hepatology 58(6) (2013) 2079-88.
X. Zhang, J. Tsauo, J. Tie, H. Xue, J.B. Zhao, J.J. Li, Z.T. Fang, W.H. Guo, X. Li, Emergent Transjugular Intrahepatic Portosystemic Shunt Creation for Acute Gastric Variceal Bleeding in Patients with Hepatocellular Carcinoma, J Vasc Interv Radiol 33(6) (2022) 702-706.
G. Garcia-Tsao, J. Bosch, Management of varices and variceal hemorrhage in cirrhosis, N Engl J Med 362(9) (2010) 823-32.
R. de Franchis, J. Bosch, G. Garcia-Tsao, T. Reiberger, C. Ripoll, V.I.I.F. Baveno, Baveno VII - Renewing consensus in portal hypertension, J Hepatol 76(4) (2022) 959-974.
O. Nicoara-Farcau, G. Han, M. Rudler, D. Angrisani, A. Monescillo, F. Torres, G. Casanovas, J. Bosch, Y. Lv, D. Thabut, D. Fan, V. Hernandez-Gea, J.C. Garcia-Pagan, I.V.B.S. Preemptive Tips Individual Data Metanalysis, g. Baveno Cooperation Study, Effects of Early Placement of Transjugular Portosystemic Shunts in Patients With High-Risk Acute Variceal Bleeding: a Meta-analysis of Individual Patient Data, Gastroenterology 160(1) (2021) 193-205 e10.
W.C. Li, B.Y. Zhong, S. Zhang, J. Shen, W. Wang, X.L. Zhu, Emergent TIPS as a first-line therapy in advanced cirrhotic patients with acute gastroesophageal variceal bleeding, J Vasc Interv Radiol (2022).
J.A. Marrero, L.M. Kulik, C.B. Sirlin, A.X. Zhu, R.S. Finn, M.M. Abecassis, L.R. Roberts, J.K. Heimbach, Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases, Hepatology 68(2) (2018) 723-750.
e.e.e. European Association for the Study of the Liver. Electronic address, L. European Association for the Study of the, EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma, J Hepatol 69(1) (2018) 182-236.
A. Forner, M. Reig, J. Bruix, Hepatocellular carcinoma, Lancet 391(10127) (2018) 1301-1314.
D. Sacks, T.E. McClenny, J.F. Cardella, C.A. Lewis, Society of Interventional Radiology clinical practice guidelines, J Vasc Interv Radiol 14(9 Pt 2) (2003) S199-202.
J.S. Bajaj, J. Cordoba, K.D. Mullen, P. Amodio, D.L. Shawcross, R.F. Butterworth, M.Y. Morgan, E. International Society for Hepatic, M. Nitrogen, Review article: the design of clinical trials in hepatic encephalopathy--an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement, Aliment Pharmacol Ther 33(7) (2011) 739-47.
R. Lencioni, J.M. Llovet, Modified RECIST (mRECIST) assessment for hepatocellular carcinoma, Semin Liver Dis 30(1) (2010) 52-60.
J. Tsauo, J. Tie, H. Xue, J.B. Zhao, J.J. Li, Z.T. Fang, W.H. Guo, X. Li, Transjugular Intrahepatic Portosystemic Shunt Creation for the Prevention of Gastric Variceal Rebleeding in Patients with Hepatocellular Carcinoma: A Multicenter Retrospective Study, J Vasc Interv Radiol 32(7) (2021) 963-969.
H. Yan, Z. Qiu, Z. Xiang, K. Feng, M. Huang, F. Gao, TIPS improves outcomes in patients with HCC and symptomatic portal hypertension: a multi-institution experience, Cancer Imaging 22(1) (2022) 13.
Z. Qiu, G. Wang, H. Yan, H. Qi, M. Zuo, G. Wang, W. Jiang, Z. Chen, J. Xue, L. Lu, F. Zhang, F. Gao, TIPS plus sequential systemic therapy of advanced HCC patients with tumour thrombus-related symptomatic portal hypertension, Eur Radiol 32(10) (2022) 6777-6787.
H. Zhao, J. Tsauo, X. Zhang, T. Gong, J. Li, X. Li, Transjugular intrahepatic portosystemic shunt creation for portal hypertension in patients with hepatocellular carcinoma: A systematic review, Int J Gastrointest Interv 7(3) (2018) 167-171.
V. Hernandez-Gea, B. Procopet, A. Giraldez, L. Amitrano, C. Villanueva, D. Thabut, L. Ibanez-Samaniego, G. Silva-Junior, J. Martinez, J. Genesca, C. Bureau, J. Trebicka, E. Llop, W. Laleman, J.M. Palazon, J. Castellote, S. Rodrigues, L.L. Gluud, C. Noronha Ferreira, R. Barcelo, N. Canete, M. Rodriguez, A. Ferlitsch, J.L. Mundi, H. Gronbaek, M. Hernandez-Guerra, R. Sassatelli, A. Dell'Era, M. Senzolo, J.G. Abraldes, M. Romero-Gomez, A. Zipprich, M. Casas, H. Masnou, M. Primignani, A. Krag, F. Nevens, J.L. Calleja, C. Jansen, M.A. Robic, I. Conejo, M.V. Catalina, A. Albillos, M. Rudler, E. Alvarado, M.A. Guardascione, M. Tantau, J. Bosch, F. Torres, J.C. Garcia-Pagan, G. International Variceal Bleeding Observational Study, C. Baveno, Preemptive-TIPS Improves Outcome in High-Risk Variceal Bleeding: An Observational Study, Hepatology 69(1) (2019) 282-293.
G.H. Lo, H.L. Liang, W.C. Chen, M.H. Chen, K.H. Lai, P.I. Hsu, C.K. Lin, H.H. Chan, H.B. Pan, A prospective, randomized controlled trial of transjugular intrahepatic portosystemic shunt versus cyanoacrylate injection in the prevention of gastric variceal rebleeding, Endoscopy 39(8) (2007) 679-85.
S.S. Sabri, N. Abi-Jaoudeh, W. Swee, W.E. Saad, U.C. Turba, S.H. Caldwell, J.F. Angle, A.H. Matsumoto, Short-term rebleeding rates for isolated gastric varices managed by transjugular intrahepatic portosystemic shunt versus balloon-occluded retrograde transvenous obliteration, J Vasc Interv Radiol 25(3) (2014) 355-61.
S.J. Lee, S.U. Kim, M.D. Kim, Y.H. Kim, G.M. Kim, S.I. Park, J.Y. Won, D.Y. Lee, K.H. Lee, Comparison of treatment outcomes between balloon-occluded retrograde transvenous obliteration and transjugular intrahepatic portosystemic shunt for gastric variceal bleeding hemostasis, J Gastroenterol Hepatol 32(8) (2017) 1487-1494.
S.K. Kim, K.A. Lee, S. Sauk, K. Korenblat, Comparison of Transjugular Intrahepatic Portosystemic Shunt with Covered Stent and Balloon-Occluded Retrograde Transvenous Obliteration in Managing Isolated Gastric Varices, Korean J Radiol 18(2) (2017) 345-354.
D. Bettinger, E. Knuppel, W. Euringer, H.C. Spangenberg, M. Rossle, R. Thimme, M. Schultheiss, Efficacy and safety of transjugular intrahepatic portosystemic shunt (TIPSS) in 40 patients with hepatocellular carcinoma, Aliment Pharmacol Ther 41(1) (2015) 126-36.
B. Qiu, K. Li, X. Dong, F.Q. Liu, Transjugular Intrahepatic Portosystemic Shunt for Portal Hypertension in Hepatocellular Carcinoma with Portal Vein Tumor Thrombus, Cardiovasc Intervent Radiol 40(9) (2017) 1372-1382.
C.F. Rose, P. Amodio, J.S. Bajaj, R.K. Dhiman, S. Montagnese, S.D. Taylor-Robinson, H. Vilstrup, R. Jalan, Hepatic encephalopathy: Novel insights into classification, pathophysiology and therapy, J Hepatol 73(6) (2020) 1526-1547.
W. Manatsathit, H. Samant, P. Panjawatanan, A. Braseth, J. Suh, M. Esmadi, N. Wiedel, T. Ingviya, Performance of ultrasound for detection of transjugular intrahepatic portosystemic shunt dysfunction: a meta-analysis, Abdom Radiol (NY) 44(7) (2019) 2392-2402.
D.M. Ruohoniemi, B. Taslakian, E.A. Aaltonen, R. Hickey, A. Patel, J.C. Horn, M. Chiarello, M. McDermott, Comparative Analysis of Safety and Efficacy of Transarterial Chemoembolization for the Treatment of Hepatocellular Carcinoma in Patients with and without Pre-Existing Transjugular Intrahepatic Portosystemic Shunts, J Vasc Interv Radiol 31(3) (2020) 409-415.
A.C. Gordon, A.N. Gupta, A. Gabr, B.G. Thornburg, L.M. Kulik, D.R. Ganger, H. Maddur, S.L. Flamm, J.R. Boike, C.M. Moore, D. Borja-Cacho, D.A. Christopher, N.N. Katariya, D.P. Ladner, J.C. Caicedo-Ramirez, A. Riaz, R. Salem, R.J. Lewandowski, Safety and Efficacy of Segmental Yttrium-90 Radioembolization for Hepatocellular Carcinoma after Transjugular Intrahepatic Portosystemic Shunt Creation, J Vasc Interv Radiol 32(2) (2021) 211-219.
J.K. Park, Q.Z. Al-Tariq, T.M. Zaw, S.S. Raman, D.S. Lu, Radiofrequency Ablation for the Treatment of Hepatocellular Carcinoma in Patients with Transjugular Intrahepatic Portosystemic Shunts, Cardiovasc Intervent Radiol 38(5) (2015) 1211-7.
H. Han, Y. Meng, J. Wang, Effect of transjugular intrahepatic portosystemic shunt combined with (125)I particle implantation on portal vein tumor thrombus in hepatocellular carcinoma, Am J Transl Res 14(3) (2022) 1838-1848.
Funding
This study was funded by Key R&D Program (Social Development) Project of Jiangsu Province (BE2021648) and the Suzhou People’s Livelihood Science and Technology Project (No. SS202059). Funding sources had no involvement in the financial support for the conduct of the research and preparation of the article.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The retrospective study was approved by the institutional review board at participating hospital. For this type of study formal consent is not required.
Informed consent
For this type of study informed consent is not required.
Consent for publication
For this type of study consent for publication is not required.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Huang, JT., Zhong, BY., Li, WC. et al. Emergent TIPS for acute gastroesophageal variceal bleeding in cirrhotic patients with hepatocellular carcinoma. Abdom Radiol 49, 900–907 (2024). https://doi.org/10.1007/s00261-023-04088-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00261-023-04088-5